Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ZLDPF Relative to the S&P 500

ZLDPF Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Zealand Pharma A/S. (OTCMKT:ZLDPF) seasonal charts above shows that a Buy Date of July 18 and a Sell Date of October 12 has resulted in a geometric average return of 13.49% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 11 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 15.2% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.

To download ZLDPF seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ZLDPF